Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001659819-17-000001
Filing Date
2017-04-20
Accepted
2017-04-20 11:11:35
Documents
1
Effectiveness Date
2017-04-20
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 11076
  Complete submission text file 0001659819-17-000001.txt   12146
Mailing Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 400 MALVERN PA 19355 484-318-2988
Velicept Therapeutics, Inc. (Filer) CIK: 0001659819 (see all company filings)

EIN.: 473400632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-252193 | Film No.: 17771917